Centre for Chronic Disease Control, India
10
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
50%
5 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
HFrEF Polypill in Sri Lanka RCT
Role: collaborator
Assessing Feasibility of a Digital Health Intervention for Multiple Long-Term Condition Care in Primary Health Settings in India and Nepal
Role: lead
Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka
Role: collaborator
Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
Role: lead
WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey
Role: collaborator
To Test the Effectiveness of a Trained Nurse Led, M-health Enabled Intervention to Control Blood Pressure in India
Role: lead
Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.
Role: lead
Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study
Role: collaborator
To Develop a High Quality Health Care Delivery Model for the Management of Hypertension and Diabetes at CHCs and District Hospitals of Himachal Pradesh.
Role: lead
Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults
Role: lead
All 10 trials loaded